Volume 12, Issue 11 (12-2014)                   IJRM 2014, 12(11): 755-0 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khanaki K, Sadeghi M R, Akhondi M M, Darabi M, Mehdizadeh A, Shabani M, et al . High ω-3:ω-6 fatty acids ratio increases fatty acid binding protein 4 and extracellular secretory phospholipase A2IIa in human ectopic endometrial cells. IJRM 2014; 12 (11) :755-0
URL: http://ijrm.ir/article-1-495-en.html
1- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
2- Umbilica Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3- Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4- Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
5- Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6- Women’s Reproductive Health Research Center, Alzahra Hospital, Tabriz University of Medical Sciences, Tabriz, Iran , nourimd@yahoo.com
Abstract:   (3157 Views)
Background: Endometriosis, a common chronic inflammatory disorder, is defined by the atypical growth of endometrium- like tissue outside of the uterus. Secretory phospholipase A2 group IIa (sPLA2-IIa) and fatty acid binding protein4 (FABP4) play several important roles in the inflammatory diseases.
Objective: Due to reported potential anti-inflammatory effects of ω-3 and ω-6 fatty acids, the purpose of the present study was to investigate the effects of ω-3 and ω-6 polyunsaturated fatty acids (PUFAs) on fatty acid binding protein 4 and extracellular secretory phospholipase A2IIa in cultured endometrial cells.
Materials and Methods: Ectopic and eutopic endometrial tissues obtained from 15 women were snap frozen. After thawing and tissue digestion, primary mixed stromal and endometrial epithelial cell culture was performed for 8 days in culture mediums supplemented with normal and high ratios of ω-3 and ω-6 PUFA. sPLA2-IIa in the culture medium and FABP4 level was determined using enzyme immuno assay (EIA) technique.
Results: Within ectopic endometrial cells group, the level of cellular FABP4 and extracellular sPLA2-IIa were remarkably increased under high ω-3 PUFA exposure compared with control condition (p=0.014 and p=0.04 respectively).
Conclusion: ω-3 PUFAs may increase the level of cellular FABP4 and extracellular sPLA2-IIa in ectopic endometrial cells, since sPLAIIa and FABP4 may affect endometriosis via several mechanisms, more relevant studies are encouraged to know the potential effect of increased cellular FABP4 and extracellular sPLA2-IIa on endometriosis.
Full-Text [PDF 404 kb]   (809 Downloads) |   |   Full-Text (HTML)  (411 Views)  
Type of Study: Original Article |

References
1. de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet 2010; 376: 730-738. [DOI:10.1016/S0140-6736(10)60490-4]
2. Arya P, Shaw R. Endometriosis: current thinking. Curr Obstet Gynaecol 2005; 15: 191-198. [DOI:10.1016/j.curobgyn.2005.03.003]
3. Nnoaham KE, Hummelshoj L, Webster P, d'Hooghe T, de Cicco Nardone F, de Cicco Nardone C, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril 2011; 96: 366-373. [DOI:10.1016/j.fertnstert.2011.05.090]
4. Somigliana E, Vigano P, Candiani M, Felicetta I, Di Blasio AM, Vignali M. Use of serum-soluble intercellular adhesion molecule-1 as a new marker of endometriosis. Fertil Steril 2002; 77:1028-1031. [DOI:10.1016/S0015-0282(02)02971-0]
5. Seli E, Berkkanoglu M, Arici A. Pathogenesis of endometriosis. Obstet Gynecol Clin North Am 2003; 30: 41-61. [DOI:10.1016/S0889-8545(02)00052-9]
6. Ulukus M, Arici A. Immunology of endometriosis. Minerva Ginecol 2005; 57: 237-248.
7. Bazan NG. Synaptic signaling by lipids in the life and death of neurons. Mol Neurobiol 2005; 31: 219-230. [DOI:10.1385/MN:31:1-3:219]
8. Murakami M, Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res 2004; 43: 33-35. [DOI:10.1016/S0163-7827(03)00037-7]
9. Wu Y, Raymond B, Goossens PL, Njamkepo E, Guiso N, Paya M, et al. Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host. Biochimie 2010; 92: 583-587. [DOI:10.1016/j.biochi.2010.01.024]
10. Chmurzynska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 2006; 47: 39-48. [DOI:10.1007/BF03194597]
11. Wang Q, Guan T, Li H, Bernlohr DA. A novel polymorphism in the chicken adipocyte fatty acid-binding protein gene (FABP4) that alters ligand-binding and correlates with fatness. Comp Biochem Physiol B Biochem Mol Biol 2009; 154: 298-302. [DOI:10.1016/j.cbpb.2009.07.002]
12. Smathers RL, Petersen DR. The human fatty acid-binding protein family: evolutionary divergences and functions. Hum Genomics 2011; 5: 170-191. [DOI:10.1186/1479-7364-5-3-170]
13. Furuhashi M, Fucho R, Gorgun CZ, Tuncman G, Cao H, Hotamisligil GS. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 2008; 118: 2640-2650. [DOI:10.1172/JCI34750]
14. Eyster KM, Klinkova O, Kennedy V, Hansen KA. Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril 2007; 88: 1505-33. [DOI:10.1016/j.fertnstert.2007.01.056]
15. Lousse JC, Defrere S, Colette S, Van Langendonckt A, Donnez J. Expression of eicosanoid biosynthetic and catabolic enzymes in peritoneal endometriosis. Hum Reprod 2010; 25: 734-741. [DOI:10.1093/humrep/dep408]
16. Covens AL, Christopher P, Casper RF. The effect of dietary supplementation with fish oil fatty acids on surgically induced endometriosis in the rabbit. Fertil Steril 1988; 49: 698-703. [DOI:10.1016/S0015-0282(16)59842-2]
17. Missmer SA, Chavarro JE, Malspeis S, Bertone-Johnson ER, Hornstein MD, Spiegelman D, et al. A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod 2010; 25: 1528-1535. [DOI:10.1093/humrep/deq044]
18. Netsu S, Konno R, Odagiri K, Soma M, Fujiwara H, Suzuki M. Oral eicosapentaenoic acid supplementation as possible therapy for endometriosis. Fertil Steril 2008; 90: 1496-1502. [DOI:10.1016/j.fertnstert.2007.08.014]
19. Krusinova E, Pelikanova T. Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis? Diabetes Res Clin Pract 2008; 82: 127-134.
20. Ravaux L, Denoyelle C, Monne C, Limon I, Raymondjean M, El Hadri K. Inhibition of interleukin-1β-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARβ and the proto-oncogene BCL-6. Mol Cell Biol 2007; 27: 8374-8387. [DOI:10.1128/MCB.00623-07]
21. Schachtrup C, Emmler T, Bleck B, Sandqvist A, Spener F. Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins. Biochem J 2004; 382: 239-245. [DOI:10.1042/BJ20031340]
22. Sergeeva MG, Aleshin SE, Grabeklis S, Reiser G. PPAR activation has dichotomous control on the expression levels of cytosolic and secretory phospholipase A2 in astrocytes; inhibition in naive, untreated cells and enhancement in LPS-stimulated cells. J Neurochem 2010; 115: 399-410. [DOI:10.1111/j.1471-4159.2010.06931.x]
23. Khanaki K, Ardekani AM, Ghassemzadeh A, Shahnazi V, Sadeghi MR, Darabi M, et al. Effect of polyunsaturated fatty acids on secretory phospholipase A2 type IIa in ectopic endometrial cells. Iran J Reprod Med 2012; 10: 321-328.
24. Ivandic B, Castellani LW, Wang XP, Qiao JH, Mehrabian M, Navab M, et al. Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. Arterioscler Thromb Vasc Biol 1999; 19: 1284-1290. [DOI:10.1161/01.ATV.19.5.1284]
25. Peilot H, Rosengren B, Bondjers G, Hurt-Camejo E. Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines. J Biol Chem 2000; 275: 22895-22904. [DOI:10.1074/jbc.M002783200]
26. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997; 24: 445-451.
27. Delbandi AA, Mahmoudi M, Shervin A, Akbari E, Jeddi-Tehrani M, Sankian M, et al. Eutopic and ectopic stromal cells from patients with endometriosis exhibit differential invasive, adhesive, and proliferative behavior. Fertil Steril 2013; 100: 761-769. [DOI:10.1016/j.fertnstert.2013.04.041]
28. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67: 817-821. [DOI:10.1016/S0015-0282(97)81391-X]
29. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 1975; 122: 262-263. [DOI:10.1016/S0002-9378(16)33500-1]
30. Bersinger NA, Frischknecht F, Taylor RN, Mueller MD. Basal and cytokine-stimulated production of epithelial neutrophil activating peptide-78 (ENA-78) and interleukin-8 (IL-8) by cultured human endometrial epithelial and stromal cells. Fertil Steril 2008; 89: 1530-1536. [DOI:10.1016/j.fertnstert.2007.05.075]
31. Bruse C, Guan Y, Carlberg M, Carlstrom K, Bergqvist A. Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells. Fertil Steril 2005; 83: 1155-1160. [DOI:10.1016/j.fertnstert.2004.09.033]
32. Gazvani MR, Smith L, Haggarty P, Fowler PA, Templeton A. High omega-3: omega-6 fatty acid ratios in culture medium reduce endometrial-cell survival in combined endometrial gland and stromal cell cultures from women with and without endometriosis. Fertil Steril 2001; 76: 717-722. [DOI:10.1016/S0015-0282(01)01991-4]
33. Yang Y, Degranpre P, Kharfi A, Akoum A. Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells. J Clin Endocrinol Metab 2000; 85: 4721-4727. [DOI:10.1210/jc.85.12.4721]
34. Zafrakas M, Tarlatzis BC, Streichert T, Pournaropoulos F, Wolfle U, Smeets SJ, et al. Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced ovarian endometriosis: a high degree of differentiation rather than malignant potential. Int J Mol Med 2008; 21: 335-344. [DOI:10.3892/ijmm.21.3.335]
35. Akoum A, Lawson C, McColl S, Villeneuve M. Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro. Mol Hum Reprod 2001; 7: 859-866. [DOI:10.1093/molehr/7.9.859]
36. Muller R. Crosstalk of oncogenic and prostanoid signaling pathways. J Cancer Res Clin Oncol 2004; 130: 429-444. [DOI:10.1007/s00432-004-0570-y]
37. Tan NS, Shaw NS, Vinckenbosch N, Liu P, Yasmin R, Desvergne B, et al. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 2002; 22: 5114-5127. [DOI:10.1128/MCB.22.14.5114-5127.2002]
38. Boiteux G, Lascombe I, Roche E, Plissonnier ML, Clairotte A, Bittard H, et al. A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells. Int J Cancer 2009; 124: 1820-1828. [DOI:10.1002/ijc.24112]
39. Ohlsson G, Moreira JM, Gromov P, Sauter G, Celis JE. Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas. Mol Cell Proteomics 2005; 4: 570-581. [DOI:10.1074/mcp.M500017-MCP200]
40. Haunerland NH, Spener F. Properties and physiological significance of fatty acid binding proteins. Adv Mol Cell Biol 2003; 33: 99-122. [DOI:10.1016/S1569-2558(03)33007-3]
41. De Santis ML, Hammamieh R, Das R, Jett M. Adipocyte-fatty acid binding protein induces apoptosis in DU145 prostate cancer cells. J Exp Ther Oncol 2004; 4: 91-100.
42. Leidy C, Linderoth L, Andresen TL, Mouritsen OG, Jørgensen K, Peters GH. Domain-induced activation of human phospholipase A2 type IIA: local versus global lipid composition. Biophys J 2006; 90: 3165-3175. [DOI:10.1529/biophysj.105.070987]
43. Buckland AG, Heeley EL, Wilton DC. Bacterial cell membrane hydrolysis by secreted phospholipases A(2): a major physiological role of human group IIa sPLA(2) involving both bacterial cell wall penetration and interfacial catalysis. Biochim Biophys Acta 2000; 1484: 195-206. [DOI:10.1016/S1388-1981(00)00018-4]
44. Canaan S, Nielsen R, Ghomashchi F, Robinson BH, Gelb MH. Unusual mode of binding of human group IIA secreted phospholipase A2 to anionic interfaces as studied by continuous wave and time domain electron paramagnetic resonance spectroscopy. J Biol Chem 2002; 277: 30984-30990. [DOI:10.1074/jbc.M203649200]
45. Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res 2004; 114: 321-327. [DOI:10.1016/j.thromres.2004.06.028]
46. Carvalho LF, Abrao MS, Biscotti C, Sharma R, Nutter B, Falcone T. Oxidative cell injury as a predictor of endometriosis progression. Reprod Sci 2013; 20: 688-698. [DOI:10.1177/1933719112466301]
47. Lambrinoudaki IV, Augoulea A, Christodoulakos GE, Economou EV, Kaparos G, Kontoravdis A, et al. Measurable serum markers of oxidative stress response in women with endometriosis. Fertil Steril 2009; 91: 46-50. [DOI:10.1016/j.fertnstert.2007.11.021]
48. Meyer MC, Rastogi P, Beckett CS, McHowat J. Phospholipase A2 inhibitors as potential anti-inflammatory agents. Curr Pharm Des 2005; 11: 1301-1312. [DOI:10.2174/1381612053507521]
49. van den Berg JJ, Op den Kamp JA, Lubin BH, Kuypers FA. Conformational changes in oxidized phospholipids and their preferential hydrolysis by phospholipase A2: a monolayer study. Biochem 1993; 32: 4962-4967. [DOI:10.1021/bi00069a035]
50. Salgo MG, Corongiu FP, Sevanian A. Enhanced interfacial catalysis and hydrolytic specificity of phospholipase A2 toward peroxidized phosphatidylcholine vesicles. Arch Biochem Biophys 1993; 304: 123-132. [DOI:10.1006/abbi.1993.1330]
51. Birts CN, Barton CH, Wilton DC. A catalytically independent physiological function for human acute phase protein group IIA phospholipase A2: cellular uptake facilitates cell debris removal. J Biol Chem 2008; 283: 5034-5045. [DOI:10.1074/jbc.M708844200]
52. Murakami M, Taketomi Y, Sato H, Yamamoto K. Secreted phospholipase A2 revisited. J Biochem 2011; 150: 233-255. [DOI:10.1093/jb/mvr088]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb